Healthcare provider profile · identity verified

Michael S Mcclincy, M.D.

Family Practice · CHARLOTTESVILLE, VA · NPI 1073504130

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	859	248
Amlodipine Besylate	Amlodipine Besylate	543	155
Rosuvastatin Calcium	Rosuvastatin Calcium	495	151
Losartan Potassium	Losartan Potassium	490	138
Lisinopril	Lisinopril	375	106
Metoprolol Succinate	Metoprolol Succinate	366	106
Omeprazole	Omeprazole	290	80
Levothyroxine Sodium	Levothyroxine Sodium	265	73
Metformin Hcl Er	Metformin Hcl	252	78
Hydrochlorothiazide	Hydrochlorothiazide	238	67
Tamsulosin Hcl	Tamsulosin Hcl	176	54
Gabapentin	Gabapentin	174	51
Furosemide	Furosemide	156	49
Allopurinol	Allopurinol	155	43
Sertraline Hcl	Sertraline Hcl	148	41
Jardiance	Empagliflozin	130	35
Alendronate Sodium	Alendronate Sodium	124	42
Carvedilol	Carvedilol	114	31
Simvastatin	Simvastatin	110	34
Ezetimibe	Ezetimibe	108	34
Trazodone Hcl	Trazodone Hcl	104	33
Eliquis	Apixaban	102	33
Pravastatin Sodium	Pravastatin Sodium	96	27
Prednisone	Prednisone	95	63
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	92	29
Pioglitazone Hcl	Pioglitazone Hcl	87	27
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	83	23
Metformin Hcl	Metformin Hcl	77	26
Pantoprazole Sodium	Pantoprazole Sodium	75	25
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	73	16
Duloxetine Hcl	Duloxetine Hcl	71	23
Fluticasone Propionate	Fluticasone Propionate	69	26
Albuterol Sulfate Hfa	Albuterol Sulfate	65	41
Tramadol Hcl	Tramadol Hcl	64	22
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	61	suppressed
Finasteride	Finasteride	56	16
Escitalopram Oxalate	Escitalopram Oxalate	54	17
Montelukast Sodium	Montelukast Sodium	52	15
Tizanidine Hcl	Tizanidine Hcl	52	21
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	52	13
Clopidogrel	Clopidogrel Bisulfate	49	17
Spironolactone	Spironolactone	49	14
Atenolol	Atenolol	48	14
Telmisartan	Telmisartan	48	13
Ozempic	Semaglutide	47	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	46	11
Potassium Chloride	Potassium Chloride	44	14
Terazosin Hcl	Terazosin Hcl	44	suppressed
Glipizide Er	Glipizide	40	11
Valsartan	Valsartan	39	14
Warfarin Sodium	Warfarin Sodium	39	11
Glimepiride	Glimepiride	37	13
Doxazosin Mesylate	Doxazosin Mesylate	36	suppressed
Synthroid	Levothyroxine Sodium	34	11
Bupropion Xl	Bupropion Hcl	33	suppressed
Buspirone Hcl	Buspirone Hcl	33	suppressed
Mirtazapine	Mirtazapine	33	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	33	20
Metoprolol Tartrate	Metoprolol Tartrate	32	14
Venlafaxine Hcl Er	Venlafaxine Hcl	32	suppressed
Citalopram Hbr	Citalopram Hydrobromide	31	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	30	27
Famotidine	Famotidine	29	suppressed
Lorazepam	Lorazepam	29	suppressed
Cephalexin	Cephalexin	28	20
Isosorbide Mononitrate Er	Isosorbide Mononitrate	28	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	27	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	25	suppressed
Breo Ellipta	Fluticasone/Vilanterol	25	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	24	suppressed
Valacyclovir	Valacyclovir Hcl	24	13
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	23	18
Zolpidem Tartrate	Zolpidem Tartrate	23	suppressed
Diclofenac Sodium	Diclofenac Sodium	22	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	22	suppressed
Nitroglycerin	Nitroglycerin	22	suppressed
Alprazolam	Alprazolam	20	suppressed
Meloxicam	Meloxicam	20	11
Sumatriptan Succinate	Sumatriptan Succinate	20	suppressed
Symbicort	Budesonide/Formoterol Fumarate	20	suppressed
Verapamil Er	Verapamil Hcl	20	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	19	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	19	suppressed
Oxycodone Hcl	Oxycodone Hcl	19	suppressed
Pregabalin	Pregabalin	19	suppressed
Torsemide	Torsemide	19	suppressed
Donepezil Hcl	Donepezil Hcl	17	suppressed
Hydralazine Hcl	Hydralazine Hcl	17	suppressed
Baclofen	Baclofen	16	suppressed
Ondansetron Odt	Ondansetron	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	14
Ventolin Hfa	Albuterol Sulfate	16	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Lansoprazole	Lansoprazole	15	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Ammonium Lactate	Ammonium Lactate	14	suppressed
Amoxicillin	Amoxicillin	14	14
Chlorthalidone	Chlorthalidone	14	suppressed
Fenofibrate	Fenofibrate	14	suppressed
Fluconazole	Fluconazole	14	12
Mupirocin	Mupirocin	14	suppressed
Nebivolol Hcl	Nebivolol Hcl	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Oxycontin	Oxycodone Hcl	14	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Doxepin Hcl	Doxepin Hcl	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Morphine Sulfate Er	Morphine Sulfate	13	suppressed
Trulicity	Dulaglutide	13	suppressed
Azithromycin	Azithromycin	12	suppressed
Bumetanide	Bumetanide	12	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	11	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	11	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Topiramate	Topiramate	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error